Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

NCT05206890 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05206890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05206890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 14, 2022
Completion date
December 31, 2032
Enrollment
490 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer